Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

Increasing use of immunosuppressive biologic therapies poses a challenge for infectious diseases. Immunosuppressed patients have a high risk for influenza complications and an impaired immune response to vaccines. The total burden of immunosuppressive conditions in the United States, including those...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Manish, Chen, Jufu, Kim, Sara, Garg, Shikha, Flannery, Brendan, Haddadin, Zaid, Rankin, Danielle, Halasa, Natasha, Talbot, H. Keipp, Reed, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392442/
https://www.ncbi.nlm.nih.gov/pubmed/32348234
http://dx.doi.org/10.3201/eid2608.191493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392442/
https://www.ncbi.nlm.nih.gov/pubmed/32348234
http://dx.doi.org/10.3201/eid2608.191493

Ejemplares similares